• Home
  • About Us
    • Our History
    • Our Aims
    • Members
    • Board of Directors
    • Auditors
    • Staff members
    • Constitutional documents and reports
  • About PH
    • Classification and WHO functional class
    • What is PAH?
    • What is CTEPH?
    • Symptoms
    • Diagnosis
    • Treatment
    • Therapies
    • ESC/ERS Guidelines
    • Research
    • PH in children
    • PH and Contraception
  • Get involved
    • Membership
    • Awareness campaigns
      • O2Kids
      • PHAE Leaders Stories
        • Gerald Fischer, PH Austria
        • Aksana, PH Belarus
        • Sabina, Bosnia and Herzegovina
        • Natalia, Bulgaria
        • Zdenka, Croatia
        • Eszter, PH Hungaria
        • Aryeh, PH Israel
        • Rima, PHA Lithuania
        • Roman, PH Moldova
        • Liliya, PHA Russia
        • Peter, PH Slovakia
        • Tadeja, PH Slovenia
        • Irene, ANHP Spain
        • Oksana, PHURDA Ukraine
      • World Pulmonary Hypertension Day
      • Rare Disease Day
      • Previous campaigns
        • Ironman
        • Selfie for PH
        • E-Postcard
        • Time Matters Campaign
        • RareConnect
        • Misc.
    • Advocacy/policy work
      • Breathe Vision 2030
      • Patient journey
      • Call to Action to improve Organ Donation and Transplantation across the EU – 2015
      • Call to Action on the Unmet Needs of Patients with Pulmonary Hypertension – 2012
      • International Patient and Carer Survey on the the impact of PH – 2011
      • Partnerships
      • Useful links
      • EU legislation on public health
    • Capacity building program
    • Collaborative Educational Programs
      • Infographics
      • PH Human
      • PH: It’s personal
      • Time to Talk
        • Patient and carer resources
        • PHA Europe member resources
      • Opening lines educational project
      • Our PH Library
    • Find Your Specialist
  • News & events
    • COVID 19
      • General information
      • PHCARE patient questionnaire
      • PH reference center survey published
      • Mini COVID-19 patient survey
      • COVID-19 awareness campaign
    • Annual PH European Conferences (APHEC)
    • Mariposa Journal
    • News
    • Newsletters
    • Calendar of events
  • Contact Us
PHA Europe
PHA Europe

Find Your Specialist

Find Your Specialist Map
Select a country
Central Europe Austria Belgium Bosnia and Herzegovina Bulgaria Croatia Czech Republic Denmark Finland France Germany Greece Hungary Israel Italy Latvia Lithuania Netherlands Norway Poland Portugal Russia Serbia Slovakia Slovenia Spain Sweden Switzerland Turkey Ukraine United Kingdom
  • Home
  • About Us
    • Our History
    • Our Aims
    • Members
    • Board of Directors
    • Auditors
    • Staff members
    • Constitutional documents and reports
  • About PH
    • Classification and WHO functional class
    • What is PAH?
    • What is CTEPH?
    • Symptoms
    • Diagnosis
    • Treatment
    • Therapies
    • ESC/ERS Guidelines
    • Research
    • PH in children
    • PH and Contraception
  • Get involved
    • Membership
    • Awareness campaigns
      • O2Kids
      • PHAE Leaders Stories
        • Gerald Fischer, PH Austria
        • Aksana, PH Belarus
        • Sabina, Bosnia and Herzegovina
        • Natalia, Bulgaria
        • Zdenka, Croatia
        • Eszter, PH Hungaria
        • Aryeh, PH Israel
        • Rima, PHA Lithuania
        • Roman, PH Moldova
        • Liliya, PHA Russia
        • Peter, PH Slovakia
        • Tadeja, PH Slovenia
        • Irene, ANHP Spain
        • Oksana, PHURDA Ukraine
      • World Pulmonary Hypertension Day
      • Rare Disease Day
      • Previous campaigns
        • Ironman
        • Selfie for PH
        • E-Postcard
        • Time Matters Campaign
        • RareConnect
        • Misc.
    • Advocacy/policy work
      • Breathe Vision 2030
      • Patient journey
      • Call to Action to improve Organ Donation and Transplantation across the EU – 2015
      • Call to Action on the Unmet Needs of Patients with Pulmonary Hypertension – 2012
      • International Patient and Carer Survey on the the impact of PH – 2011
      • Partnerships
      • Useful links
      • EU legislation on public health
    • Capacity building program
    • Collaborative Educational Programs
      • Infographics
      • PH Human
      • PH: It’s personal
      • Time to Talk
        • Patient and carer resources
        • PHA Europe member resources
      • Opening lines educational project
      • Our PH Library
    • Find Your Specialist
  • News & events
    • COVID 19
      • General information
      • PHCARE patient questionnaire
      • PH reference center survey published
      • Mini COVID-19 patient survey
      • COVID-19 awareness campaign
    • Annual PH European Conferences (APHEC)
    • Mariposa Journal
    • News
    • Newsletters
    • Calendar of events
  • Contact Us
Donate Now

GRIPHON

  1. Home /
  2. Posts tagged "GRIPHON"
Back To Home
PHA Europe 2014 September
Newsletter 2014.09.29.

PHA Europe 2014 September

New developments in treatments and treatment strategies for pulmonary hypertension The two largest congresses in the fields of cardiology and respiratory medicine have taken place recently and it was very encouraging to see that a number of sessions were dedicated to pulmonary arterial hypertension and
CTEPHERAERSESCGRIPHON
Read more

Main office

PHA Europe
  • Wilhelmstraße 21, A-1120 Vienna, Austria
  • (+43) 1 402 3725
  • info@phaeurope.org

Legal

  • Sponsors
  • Imprint
  • Terms & Conditions
  • Privacy Statement
  • Disclaimer
  • Sitemap

Facebook

Recent News

APHEC 2020

APHEC 2020

APHEC, News 2021.04.05.
ERS Vision Live: Living with rare respiratory diseases through the COVID-19 pandemic

ERS Vision Live: Living with rare respiratory diseases through the COVID-19 pandemic

News 2021.03.19.
Invitation to PHA Europe’s virtual annual conference (APHEC)

Invitation to PHA Europe’s virtual annual conference (APHEC)

APHEC, News 2021.02.22.
PHA Europe - Footer logo

PHA Europe works together with its members to enhance awareness of PH across Europe, promote optimal standards of care for people living with the disease, ensure the availability of all approved treatments and encourage research for new medicines and therapies.

Copyright © 2021 - PHA Europe - All rights reserved.